Equine Rabies Immunoglobulin

The pain associated with Equine Rabies Immunoglobulin administration varies by individual pain tolerance. The injection is typically given at the bite site, which can be painful. A larger volume may be necessary to effectively treat the wound and alleviate pain.

Rabies is entirely preventable. When used alongside proper wound care and the anti-rabies vaccine (ARV), Equine Rabies Immunoglobulin is highly effective in preventing rabies, even after high-risk exposure.

Equine Rabies Immunoglobulin should be administered intramuscularly. If a large volume is needed (greater than 2 mL for children or 5 mL for adults), it should be divided among different sites. It is important to administer the immunoglobulin and the anti-rabies vaccine at separate injection sites.

Equine Rabies Immunoglobulin is not necessary for patients who have completed a full rabies vaccination series.

Equine Rabies Immunoglobulin is more cost-effective than human rabies immunoglobulin (HRIG), making it more accessible for patients in developing countries like India. However, it carries a risk of severe allergic reactions, including anaphylaxis and serum sickness, which makes some physicians cautious about its use.